Crossmark Global Holdings’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-10,119
| Closed | -$100K | – | 1435 |
|
2021
Q2 | $100K | Hold |
10,119
| – | – | ﹤0.01% | 1410 |
|
2021
Q1 | $117K | Sell |
10,119
-713
| -7% | -$8.24K | ﹤0.01% | 1404 |
|
2020
Q4 | $105K | Sell |
10,832
-2,415
| -18% | -$23.4K | ﹤0.01% | 1366 |
|
2020
Q3 | $119K | Sell |
13,247
-400
| -3% | -$3.59K | ﹤0.01% | 1291 |
|
2020
Q2 | $168K | Hold |
13,647
| – | – | ﹤0.01% | 1266 |
|
2020
Q1 | $123K | Sell |
13,647
-3,126
| -19% | -$28.2K | ﹤0.01% | 1146 |
|
2019
Q4 | $164K | Hold |
16,773
| – | – | ﹤0.01% | 1354 |
|
2019
Q3 | $115K | Sell |
16,773
-201
| -1% | -$1.38K | ﹤0.01% | 1320 |
|
2019
Q2 | $157K | Sell |
16,974
-712
| -4% | -$6.59K | ﹤0.01% | 1338 |
|
2019
Q1 | $277K | Hold |
17,686
| – | – | 0.01% | 1159 |
|
2018
Q4 | $273K | Hold |
17,686
| – | – | 0.01% | 1133 |
|
2018
Q3 | $381K | Hold |
17,686
| – | – | 0.01% | 1153 |
|
2018
Q2 | $430K | Sell |
17,686
-503
| -3% | -$12.2K | 0.01% | 1047 |
|
2018
Q1 | $311K | Sell |
18,189
-600
| -3% | -$10.3K | 0.01% | 1242 |
|
2017
Q4 | $356K | Sell |
18,789
-3,550
| -16% | -$67.3K | 0.01% | 1254 |
|
2017
Q3 | $393K | Buy |
+22,339
| New | +$393K | 0.01% | 1119 |
|
2016
Q3 | $393K | Buy |
+22,339
| New | +$393K | 0.01% | 1119 |
|